The legacy of Viagra and its impact on the pharmaceutical landscape presents a complex question for potential backers. Initially a blockbuster drug, copycat medications have significantly chipped away at its market share , creating challenges for companies involved to the original patent holder and subsequent formulas. While particular companies mi